65
Views
11
CrossRef citations to date
0
Altmetric
Bio and food sciences

Allergenicity of main celery allergen rApi g1 and high-pressure treatment

, , , , , , , , & show all
Pages 686-694 | Received 04 Sep 2009, Published online: 15 Dec 2009
 

Abstract

The structural changes and allergenicity of recombinant main celery allergen rApi g1 caused by the high pressure were studied. We have treated the buffer solutions of rApi g1 by high pressure at 500 MPa for pressure holding times 10 and 20 min and holding time temperatures 30 °C, 40 °C and 50 °C. The structural changes were studied by circular dichroismus (CD) spectra. The allergenic reaction of the rApi g1 was tested by Western blot analysis. The greatest changes of the structure were found at samples treated by 500 MPa at 50 °C. The samples treated at this temperature at pressure levels 400, 450 and 500 MPa and held for 10 and 20 min showed that protein structure changes are positively correlated with pressure. Western blot analysis evidenced that a pressure of 500 MPa held for 10–20 min at temperatures 30–50 °C did not change the allergenicity of the rApi g1 protein when compared with the untreated sample.

Acknowledgements

The authors thank Dr Ondrej Julinek, Institute of Chemical Technology in Prague, for precise analysis of the structure changes by the ECD dichroismus method. Our work was supported by grant no. 2B06139

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.